These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10945379)

  • 1. Antithrombin in severe sepsis--"new" indication of an "old" drug?
    Riess H
    Intensive Care Med; 2000 Jun; 26(6):657-9. PubMed ID: 10945379
    [No Abstract]   [Full Text] [Related]  

  • 2. Continuing challenges of sepsis research.
    Crowther MA; Marshall JC
    JAMA; 2001 Oct; 286(15):1894-6. PubMed ID: 11597294
    [No Abstract]   [Full Text] [Related]  

  • 3. Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial.
    Warren BL; Eid A; Singer P; Pillay SS; Carl P; Novak I; Chalupa P; Atherstone A; Pénzes I; Kübler A; Knaub S; Keinecke HO; Heinrichs H; Schindel F; Juers M; Bone RC; Opal SM;
    JAMA; 2001 Oct; 286(15):1869-78. PubMed ID: 11597289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of anticoagulants in patients with sepsis.
    Langer M; Riccardi F; Piovella F; Klersy C
    JAMA; 2002 Jan 23-30; 287(4):448-9. PubMed ID: 11798358
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of antithrombin III (ATIII) for disseminated intravascular coagulation (DIC) during septic shock.
    Cohendy R; Lefrant JY; de la Coussaye JE
    Intensive Care Med; 1998 Dec; 24(12):1344. PubMed ID: 9885894
    [No Abstract]   [Full Text] [Related]  

  • 6. Antithrombin (AT) substitution: sense or nonsense?
    Köhler M
    Anaesthesia; 1998 May; 53 Suppl 2():52-4. PubMed ID: 9659067
    [No Abstract]   [Full Text] [Related]  

  • 7. [[Antithrombin III concentrates in the treatmetn of sepsis and septic shock: indictions, limits and future prospects] ].
    Baudo F; de Cataldo F
    Minerva Anestesiol; 2000 Nov; 66(11 Suppl 1):3-23. PubMed ID: 11213542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombin III modulator of coagulation and inflammatory reaction.
    Gajek H
    Acta Anaesthesiol Scand Suppl; 1997; 111():221-2. PubMed ID: 9421022
    [No Abstract]   [Full Text] [Related]  

  • 9. [Are there certified indications for the use of antithrombin III in intensive care].
    Kulka PJ; Tryba M; Lange S
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Mar; 36(3):143-53. PubMed ID: 11324345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antithrombin III in severe sepsis and septic shock].
    Carrillo-Esper R; Núñez-Monroy FN
    Gac Med Mex; 1999; 135(4):443-6. PubMed ID: 10491905
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anti-inflammatory therapy in sepsis].
    Briegel J; Weis F; Kilger E
    Chirurg; 2003 Jun; 74(6):590-1; author reply 591-2. PubMed ID: 12916500
    [No Abstract]   [Full Text] [Related]  

  • 12. Antithrombin III in Sepsis. New evidences and open questions.
    Ostermann H
    Minerva Anestesiol; 2002 May; 68(5):445-8. PubMed ID: 12029261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The response of antithrombin III activity after supplementation decreases in proportion to the severity of sepsis and liver dysfunction.
    Hayakawa M; Sawamura A; Yanagida Y; Sugano M; Hoshino H; Gando S
    Shock; 2008 Dec; 30(6):649-52. PubMed ID: 18496242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic therapies for sepsis: a need for more studies.
    Minneci PC; Deans KJ; Cui X; Banks SM; Natanson C; Eichacker PQ
    Crit Care Med; 2006 Feb; 34(2):538-41. PubMed ID: 16424739
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pathophysiology of sepsis and possible influence of statins].
    Fraunberger P; Drexel H; Walli AK
    Dtsch Med Wochenschr; 2010 Oct; 135(43):2128-32. PubMed ID: 20960384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombin III in animal models of sepsis and organ failure.
    Dickneite G
    Semin Thromb Hemost; 1998; 24(1):61-9. PubMed ID: 9515781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with antithrombin III concentrates in critically ill patients with sepsis and multiple organ failure.
    Eisele B; Lamy M
    Semin Thromb Hemost; 1998; 24(1):71-80. PubMed ID: 9515782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of antithrombin III in inhalation injury.
    Latenser BA
    J Burn Care Res; 2009; 30(1):186-8. PubMed ID: 19060754
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antithrombin therapy of no value in sepsis according to a large clinical trial].
    Gårdlund B
    Lakartidningen; 2002 Mar; 99(13):1456-7, 1460. PubMed ID: 11989356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation inhibitors in sepsis and disseminated intravascular coagulation.
    Lee WL; Downey GP
    Intensive Care Med; 2000 Nov; 26(11):1701-6. PubMed ID: 11193281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.